hero image

Biogen to Present at the Leerink Partners 5th Annual Global Healthcare Conference

February 4, 2016 News Release

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Inc. (NASDAQ: BIIB) announced today that it will present at the Leerink Partners 5th Annual Global Healthcare Conference. The webcast will be live on Thursday, February 11, 2016, at 2:15p.m. ET. To access the live webcast, please visit Biogen’s Investors section at www.biogen.com. An archived version of the webcast will be available for 14 days following the presentation.

About Biogen
Through cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological, autoimmune and rare diseases. Founded in 1978, Biogen is one of the world’s oldest independent biotechnology companies and patients worldwide benefit from its leading multiple sclerosis and innovative hemophilia therapies. For more information, please visit www.biogen.com. Follow us on Twitter.

 

Contact:

Biogen
Karen Jewell, 781-464-2442
Investor Relations

thumb
March 4, 2024
Biogen Highlights New Data at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™) 2024 Annual Meeting

New data advances understanding of new approaches to treating Alzheimer’s disease Research on disease progression could help inform future clinical trials CAMBRIDGE, Mass., March 04, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced it will present new data from its Alzheimer’s disease

thumb
February 26, 2024
Biogen to Participate in the TD Cowen 44th Annual Health Care Conference

Cambridge, MA, - -  Biogen Inc. (Nasdaq: BIIB) announced today that Michael McDonnell, Chief Financial Officer, Priya Singhal, M.D., M.P.H., Head of Development, and Alisha Alaimo, Head of North America, will participate in a fireside chat during the TD Cowen 44th Annual Health Care Conference.